If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e),
13d-1(f) or 13d-1(g), check the following box
¨
.
Note. Schedules filed in paper format shall
include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom
copies are to be sent.
CUSIP No. 45112X107
|
13D
|
Page 2 of 5 Pages
|
1
|
NAME OF REPORTING PERSONS:
Parity Labs, LLC
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
(a)
¨
(b)
¨
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS* OO
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e)
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF SHARES
|
7
|
SOLE VOTING POWER
20,000,000 (1)
|
BENEFICIALLY
OWNED BY
|
8
|
SHARED VOTING POWER
-0-
|
|
9
|
SOLE DISPOSITIVE POWER
20,000,000 (1)
|
PERSON WITH
|
10
|
SHARED DISPOSITIVE POWER
-0-
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
20,000,000 (1)
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES*
|
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AGGREGATE AMOUNT IN ROW (11)
8.03% (2)
|
14
|
TYPE OF REPORTING PERSON*
Parity Labs, LLC: OO
|
(1) As of the date of the event which requires
filing of this Schedule 13D, the Reporting Person beneficially owns 20,000,000 shares of common stock, which includes a common
stock option to acquire 20,000,000 shares of common stock at $0.05 per share.
(2) Percentage of class calculated based
on an aggregate of 229,196,550 shares issued and outstanding, after giving effect to the transactions described in Item 4 of this
Schedule 13D.
Item 1. Security and Issuer.
This Schedule 13D relates to the Common
Stock, par value $0.0001 per share (the “Common Stock”), of ID Global Solutions Corporation, a Delaware corporation
(the “Issuer”). The Issuer’s principal executive offices are located at 160 East Lake Brantley Drive, Longwood,
Florida 32779.
Item 2. Identity and Background.
This statement is being filed by and on
behalf of Parity Labs, LLC (“Reporting Person”).
The address of the
principal office of the Reporting Person is 780 Long Beach Road, Long Beach, NY 11561.
Reporting Person is
principally involved in the business of consulting.
Reporting Person is
a citizen of the United States.
Reporting Person is
an accredited investor.
During the last five
years, the Reporting Person has not (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors)
or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such
proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities
subject to, federal or state securities laws or finding any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration.
On August 10, 2016, the Issuer entered
into that certain Letter Agreement with the Reporting Person to amend the compensation section of that certain Advisory Agreement
previously entered into between Issuer and Reporting Person on November 16, 2015 for the provision of strategic advisory services,
to provide for the issuance to Reporting Person of a common stock option (the "Option") to acquire 20,000,000 shares
of common stock of Issuer exercisable at $0.05 per share for a period of ten years. The Option vests as to 10,000,000 shares of
common stock immediately and then in 12 equal tranches of 833,333 shares per month commencing on September 1, 2016.
The issuance of the
Option was made in reliance upon exemptions from registration pursuant to section 4(2) under the Securities Act of 1933 and/or
Rule 506 promulgated under Regulation D thereunder. The Reporting Person is an accredited investor as defined in Rule 501 of Regulation
D promulgated under the Securities Act of 1933.
The Reporting Person
did not acquire beneficial ownership of the shares of common stock with borrowed funds.
The Reporting Person
did not acquire beneficial ownership of any securities with borrowed funds.
Item 4. Purpose of Transaction.
The Reporting Person
has acquired the securities of the Issuer for investment purposes, and such purchases have been made in the Reporting Person’s
ordinary course of business.
Item 5. Interest in Securities of the
Issuer.
As of August 10, 2016,
the Reporting Person beneficially owned an aggregate of 20,000,000 or 8.03% of Issuer’s common stock.
Except as described
in this Schedule 13D, the Reporting Person has not effectuated any other transactions involving the securities in the last 60 days.
Item 6. Contracts, Arrangements, Understandings
or Relationships with Respect to Securities of the Issuer.
Other than as described
in this Schedule 13D, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting
Person and any other person with respect to any securities of the Issuer.
Item 7. Material to be Filed as Exhibits.
Exhibit
No.
|
|
Description of Exhibit
|
|
|
|
4.1
|
|
Stock Option issued to Parity Labs, LLC (1)
(1) Incorporated by reference to the Form 8-K Current Report
filed August 16, 2016
|
SIGNATURES
After reasonable inquiry
and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and accurate.
October 7, 2016
|
PARITY LABS, LLC
|
|
By:
|
/s/Stephen Fleming
|
|
|
Name: Stephen Fleming
|
|
Title: Attorney-in-Fact
|